On Monday, Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), lost -6.12% to $34.82. 1.65 million shares of the company were exchanged.
Sarepta Therapeutics, Inc. (SRPT), a developer of innovative RNA-targeted therapeutics, declared the closing of its formerly declared underwritten public offering of an aggregate of 3,250,000 shares of its common stock at a price to the public of $39.00 per share. The gross proceeds from the offering, before deducting the underwriter discounts and commissions and other offering expenses, were about $127 million. In addition, Sarepta has granted the underwriters a 30-day option to purchase up to an additional 487,500 shares of common stock on the same terms and conditions as the initial shares sold to the underwriters.
Credit Suisse and Morgan Stanley acted as joint book-running managers for the offering. In addition, Baird, William Blair, Needham & Company, Oppenheimer & Co. and Roth Capital Partners acted as co-managers for the offering.
Sarepta intends to use the net proceeds from the offering principally for product and commercial development, manufacturing, any business development activities and for general corporate purposes.
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases.
Shares of Welltower Inc (NYSE:HCN), declined -0.30% to $69.05, during its last trading session.
Welltower Inc. (HCN) declared that it has priced a public offering of $500 million in a re-opening of its 4.0% notes due June 1, 2025. The notes were priced at 97.750% of their face amount to yield 4.287%. Subject to customary closing conditions, the offering is predictable to close on October 19, 2015.
The company intends to use the net proceeds from this offering to repay advances under its primary unsecured credit facility and for general corporate purposes, counting investing in health care and seniors housing properties. Pending such use, the net proceeds may be invested in short-term, investment grade, interest-bearing securities, certificates of deposit or indirect or guaranteed obligations of the United States.
Welltower Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets.
At the end of Monday’s trade, Shares of Phillips 66 (NYSE:PSX), inclined 0.42% to $83.87.
Phillips 66 (PSX) declares its 2016 capital budget of $3.6 billion, not taking into account Phillips 66 Partners’ capital program. The board of directors of Phillips 66 also approved a $2.0 billion enhance to the company’s share repurchase program.
Not Taking Into Account Phillips 66 Partners’ capital spending, Phillips 66 plans to invest $2.0 billion in its Midstream business lines. In Natural Gas Liquids (NGL), the company continues construction of the 4.4 million-barrel-per-month Freeport LPG Export Terminal on the U.S. Gulf Coast, with completion predictable in the second half of 2016. In addition, the budget comprises spending associated with expansion of the Sweeny NGL midstream hub.
In Transportation, the company is investing in the new DAPL and ETCOP pipeline projects to move crude oil from the Bakken production area of North Dakota to market centers throughout the United States. Storage capacity is being added at the Beaumont Terminal in Nederland, Texas, and the company is investing in the Bayou Bridge pipeline project to move crude oil from Texas to Louisiana markets.
Phillips 66 operates as an energy manufacturing and logistics company. It operates through four segments: Midstream, Chemicals, Refining, and Marketing and Specialties (M&S).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
